IL-17 contributes to CD4-mediated graft-versus-host disease. - Wikidata - wikimedia - TriplyDB

IL-17 contributes to CD4-mediated graft-versus-host disease.

IL-17 contributes to CD4-mediated graft-versus-host disease.

http://www.wikidata.org/entity/Q37071147

about

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease Current data on IL-17 and Th17 cells and implications for graft versus host disease.Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease Kinetics of IFN-γ and IL-17 Production by CD4 and CD8 T Cells during Acute Graft-versus-Host Disease.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.TLR signals promote IL-6/IL-17-dependent transplant rejection.An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?Heparanase upregulates Th2 cytokines, ameliorating experimental autoimmune encephalitis.SOCS3 regulates graft-versus-host disease.Advances in graft-versus-host disease biology and therapy.Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses.A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation.Development of a T(H)17 immune response during the induction of murine syngeneic graft-versus-host disease Th17 immune responses contribute to the pathophysiology of aplastic anemia.Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.Th17/Treg ratio in human graft-versus-host disease.Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation.Dectin-1: a role in antifungal defense and consequences of genetic polymorphisms in humans.Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease.Muramyl dipeptide induces Th17 polarization through activation of endothelial cells.Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease Investigating the relationship between serum interleukin-17 levels and systemic immune-mediated disease in patients with dry eye syndrome Sequential activation of inflammatory signaling pathways during graft-versus-host disease (GVHD): early role for STAT1 and STAT3.Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.Effects of Pre-conditioning Dose on the Immune Kinetics and Cytokine Production in the Leukocytes Infiltrating GVHD Tissues after MHC-matched Transplantation.HDAC inhibition and graft versus host disease Interleukin-17 in various ocular surface inflammatory diseases Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cells IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice.Absence of Stat1 in donor CD4⁺ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice Bone marrow and the control of immunity.Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes.Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt.

P2860

Q26751959-9E8201A0-834E-4138-B9DF-E4CF0D027972 Q27008309-75EBBF0A-D5B7-4F90-871E-FFFB616E0ED3 Q28076264-91CAB3C4-37CE-46C1-8E79-DD06D42F0E1C Q30654527-6EE060E0-0F48-4D3D-8976-A5C200EBDC7C Q33564445-55714869-4526-42A8-9E0C-52AF94696551 Q33584409-FAFFB371-77C8-4A0C-89BB-CD73D04131F9 Q33619021-8A866896-9B90-46C6-8831-99666351382F Q33685495-20648E57-DB82-4F4F-9598-08ADC42C4234 Q33711191-3AD43BBA-61B6-43D6-B5B4-BE47B27F3B32 Q33798102-A728733F-F961-4C3B-87DE-A1968C9255A6 Q33800533-A709C62E-D870-4B0D-97EE-40137D69FA4C Q33833954-2F0BCB1B-7003-4DB6-BFD2-AB5FB2E5ADF0 Q34022451-9D79AE49-F088-48B5-8E26-46A4F80AF498 Q34031916-EE7A9F85-0D26-46ED-9BD3-C358FC8728FD Q34033872-EF79FDDF-3B39-46B5-8753-1AEEAFDFAC20 Q34058468-898AF7D7-A9B2-4AB7-8531-B81C15347433 Q34288251-1A369BFB-44AD-4522-95D3-CD8C996A20B6 Q34360341-71458A1F-7CAB-4E3E-84EB-4E3D4C2DEF77 Q34400439-5E937E1C-A80E-4518-A9B4-43559898E17D Q34403757-6A3D9C0A-B2D9-45DE-BBB9-215FD7F98B76 Q34506636-6A913214-12DE-4D90-8934-C5A0B836A78F Q34520982-7BB7A98A-DB95-4349-BA87-DFD84CD1A76E Q34568892-9A97921F-EB7C-4B34-9588-76A3A5B609B3 Q34625182-93CB9173-E346-447C-AAF8-6B423473FB3B Q34643444-2046A5C2-8E1E-4E27-8D22-7C62EDFBD35B Q34695038-C0BAE17B-A7CE-4EDF-9E7B-4E4DCEDA7430 Q34703720-4EAACC83-CF3A-4365-874A-C29B4B71D8EB Q34754302-6F6C493B-4BEF-4596-9B71-E03D952EE0EC Q34772275-50B225A1-A190-49B2-8412-17400C643C35 Q35016985-DBA6738C-CB5F-4463-B0A6-C5C060AFD90A Q35072565-3F75F5B5-7104-403A-BCE5-43F3B67EA3C4 Q35112265-6D13628D-CD18-4ED2-961B-24C9F36E1B53 Q35207094-E6A12E10-0C76-4A37-B0F7-64F486C21C4B Q35212357-CEF80FDE-D213-4B25-B3A5-397C74CFA70A Q35348407-F767B1D3-A386-481D-8232-48C1F7A5C1CB Q35525708-AA8F1A92-2D57-4BDF-9D63-F361395995DB Q35572384-A7EA951C-9669-4EA5-AB41-3273144E9F99 Q35653129-9EFBA269-7523-41E0-8105-CDE9BD3597D1 Q35669245-E397D5E6-B359-432E-A735-C3AFD8488AA2 Q36139724-AC354CF7-E513-4D10-AA06-AFB1A80B0CE7

P2860

IL-17 contributes to CD4-mediated graft-versus-host disease.

http://www.wikidata.org/entity/Q37071147

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

IL-17 contributes to CD4-mediated graft-versus-host disease.

@en

IL-17 contributes to CD4-mediated graft-versus-host disease.

@nl

type

label

IL-17 contributes to CD4-mediated graft-versus-host disease.

@en

IL-17 contributes to CD4-mediated graft-versus-host disease.

@nl

prefLabel

IL-17 contributes to CD4-mediated graft-versus-host disease.

@en

IL-17 contributes to CD4-mediated graft-versus-host disease.

@nl

P1433

Q37071147-77397220-EF3D-4CCB-80B8-DB16464016A0

P1476

Q37071147-958FF87C-34A6-492B-9BA0-E95F8003486A

P2093

Q37071147-0600468C-AE85-4908-B242-6DC21D0D362C

Q37071147-10BB4E40-BAA9-4477-92D1-B9035AA62209

Q37071147-300BD947-A4F2-4E0E-BA28-33CB8B1DBE5C

Q37071147-7AE4B60C-6A0C-4EC4-9C01-4601447F108C

Q37071147-8BCB65EA-7F71-4B27-929F-EA594F45B692

Q37071147-9D170D77-7FE6-4534-819A-6E0A5A417CC2

Q37071147-C2A17C02-F6EE-435F-9F9A-4049368C8EB7

Q37071147-C655BB39-F9D3-47F7-AC87-6CD9B68A3B04

Q37071147-CBE734C0-30E3-47A1-AA4E-926E74B07E75

Q37071147-D0B1F54E-B3DA-43C5-9788-C9677DCDE344

P2860

Q37071147-12B216F8-96D4-457C-9435-7785E116AC7C

Q37071147-25076625-ECB8-471C-B2DB-1032A5D5D3BD

Q37071147-317C02AC-E635-4559-B103-16BEC1116E64

Q37071147-3217A82B-6A8A-4519-8713-D40AFBF82173

Q37071147-34424193-9178-44F1-BF1D-48D6498687AA

Q37071147-36BCA487-139D-4038-9248-1F8F8CE3A883

Q37071147-3F1F5D75-3E52-4E93-B020-69D17DDE433C

Q37071147-44140048-F426-406C-8E1D-D1D687ABB615

Q37071147-4DF804C4-7D90-4050-AB73-37D33BC3C3B8

Q37071147-5FD953EE-F0B5-4767-AD2C-90EFBE8619C3

P304

Q37071147-69CF146C-5AB1-4211-9BB9-6E71F5888C37

P31

Q37071147-B365073F-42D3-42B2-ACB1-A996BD57B309

P356

Q37071147-9B222F27-99C0-42D0-8295-92F6E74D7D6B

P407

Q37071147-4803CE37-4E27-4B5D-8292-418E289BAB06

P433

Q37071147-8FC3DCC1-E275-48AC-88E3-244A618E9D41

P478

Q37071147-36368AE0-14E1-4116-A572-D0A7065F94AC

P50

Q37071147-18BAA052-991C-4055-859D-652628C8985A

Q37071147-1BB8C8FE-EA4C-4E57-9C60-0C60BE9B9FFD

P577

Q37071147-FFC72574-7154-4C87-A3B9-3D3BE4DFE26A

P5875

Q37071147-6297B815-B164-4695-B4ED-E8A426CAD2C6

P698

Q37071147-1A71AC6D-E7B7-4C41-BD79-6070D77A18E1

P932

Q37071147-0D1D8ADD-74AD-490E-BA25-99B4464A4CA6

P356

BLOOD-2008-08-172155

P1433

P1476

IL-17 contributes to CD4-mediated graft-versus-host disease.

@en

P2093

Amanda M Holland

http://www.w3.org/2001/XMLSchema#string

Cassandra Ligh

http://www.w3.org/2001/XMLSchema#string

Chen Liu

http://www.w3.org/2001/XMLSchema#string

Christopher G King

http://www.w3.org/2001/XMLSchema#string

David Y Suh

http://www.w3.org/2001/XMLSchema#string

Gabrielle L Goldberg

http://www.w3.org/2001/XMLSchema#string

Glenn Heller

http://www.w3.org/2001/XMLSchema#string

Jeremy Grubin

http://www.w3.org/2001/XMLSchema#string

Lucy W Kappel

http://www.w3.org/2001/XMLSchema#string

Marcel R M van den Brink

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

Tumor-specific Th17-polarized cells eradicate large established melanoma

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

Transforming growth factor-beta induces development of the T(H)17 lineage

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma

Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

P304

945-952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-08-172155

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Yoichiro Iwakura

P577

2008-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23394950

http://www.w3.org/2001/XMLSchema#string

P698

18931341

http://www.w3.org/2001/XMLSchema#string

P932

2630280

http://www.w3.org/2001/XMLSchema#string